financetom
Business
financetom
/
Business
/
European Commission Fines Teva $502.8 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
European Commission Fines Teva $502.8 Million
Nov 3, 2024 3:34 PM

08:12 AM EDT, 10/31/2024 (MT Newswires) -- The European Commission on Thursday said it has fined Teva Pharmaceutical Industries ( TEVA ) 462.6 million euros ($502.8 million) for allegedly delaying competition to its medicine for the treatment of multiple sclerosis, Copaxone.

"The Commission found that Teva artificially extended the patent protection of Copaxone and systematically spread misleading information about a competing product to hinder its market entry and uptake," the commission said.

Teva did not immediately reply to a request for comment from MT Newswires.

Price: 18.49, Change: -0.10, Percent Change: -0.54

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved